A new, higher-dose formulation of a drug used to treat pancreatic disorders is now available, the drug's manufacturer said.
A Food and Drug Administration advisory committee voted last week not to recommend approval of a drug from Eli Lilly.
Drug maker Eli Lilly has finished its acquisition of a company developing a pancreatic disorder...
Drug maker Eli Lilly is moving to acquire a company developing an enzyme-replacement therapy, Lilly...
The Food and Drug Administration has granted an additional approval to a pancreatic enzyme drug...